(Q37117517)

18 August 2017

1 reference

title

Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis (English)

1 reference

Anesthesiology and pain medicine

18 August 2017

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

6 December 2022

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

6 December 2022

author name string

J. A. Markenson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836280

6 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1836280

6 December 2022

publication date

1 October 1991

1 reference

full work available at URL

18 August 2017

https://api.elsevier.com/content/article/PII:0049017291900463?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

https://api.elsevier.com/content/article/PII:0049017291900463?httpAccept=text/plain

6 December 2022

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Seminars in Arthritis and Rheumatism

6 December 2022

published in

1 reference

18 August 2017

volume

21

1 reference

18 August 2017

issue

2 Suppl 1

1 reference

18 August 2017

page(s)

4-12

1 reference

Survival, prognosis, and causes of death in rheumatoid arthritis

18 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Rheumatoid arthritis. Pathophysiology and implications for therapy

6 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Review of UK data on the rheumatic diseases--2. Rheumatoid arthritis

6 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

1958 REVISION of diagnostic criteria for rheumatoid arthritis

6 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

6 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Measurement of patient outcome in arthritis

6 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire

6 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

The arthritis impact measurement scales. Further investigations of a health status measure

6 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

The economic impact of the rheumatic diseases in the United States

6 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years

6 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Work disability among women with rheumatoid arthritis. The relative importance of disease, social, work, and family factors

6 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis

6 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

A summary of the impact of musculoskeletal conditions in the United States

6 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial

6 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Substantial work disability and earnings losses in individuals less than age 65 with osteoarthritis: Comparisons with rheumatoid arthritis

6 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Morbidity impact of rheumatoid arthritis on society

6 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

A multicenter study of hospitalization in rheumatoid arthritis. Frequency, medical-surgical admissions, and charges

6 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

The cost effectiveness of auranofin: results of a randomized clinical trial

6 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Psychosocial aspects of rheumatic disease: the developing biopsychosocial framework

6 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Validity of the Center for Epidemiological Studies Depression Scale in arthritis populations

6 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Elevated MMPI scores for hypochondriasis, depression, and hysteria in patients with rheumatoid arthritis reflect disease rather than psychological status

6 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

The GERI-AIMS. Reliability and validity of the arthritis impact measurement scales adapted for elderly respondents

6 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Report for Children and their Parents

6 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Are there secular trends in the occurrence and severity of rheumatoid arthritis?

6 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Immunogenetic heterogeneity of rheumatoid arthritis

6 December 2022

36

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Cancer morbidity in rheumatoid arthritis

6 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.

6 December 2022

44

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Factors influencing mortality in rheumatoid arthritis.

6 December 2022

45

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Cancer mortality in patients with rheumatoid arthritis

6 December 2022

46

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Survival in rheumatoid arthritis

6 December 2022

47

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Increased Mortality Among Persons with Rheumatoid Arthritis, But Where RA Does Not Appear on Death Certificate:Eleven-Year Follow-Up of an Epidemiological Study

6 December 2022

48

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Australian mortality statistics for rheumatoid arthritis 1950-81: analysis of death certificate data

6 December 2022

49

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Length of life and cause of death in rheumatoid arthritis

6 December 2022

50

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Survivorship and Death in Rheumatoid Arthritis

6 December 2022

51

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Mortality among arthritics

6 December 2022

52

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients

6 December 2022

54

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study

6 December 2022

58

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases.

6 December 2022

59

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

Long-term outcome of treating rheumatoid arthritis: results after 20 years

6 December 2022

60

1 reference

https://api.crossref.org/works/10.1016/0049-0172(91)90046-3

6 December 2022

Identifiers

1 reference

18 August 2017

1 reference